Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:PTLE News 4 November 2025

PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

PTL Limited (PTLE) Stock Soars on Surprise Profit Amid Delisting Risks – Key Facts & Outlook

Recent News – Earnings Spark a Relief Rally PTL Limited’s latest financial report (released Nov 3, 2025) revealed an unexpected profit, igniting a sharp rally in its beaten-down stock. The Hong Kong–based marine fuel logistics company announced unaudited results for the six months ended June 30, 2025, highlighting a net income of $1.21 million, up from just $0.32 M in the same period a year priorglobenewswire.com. This 277% profit jump came despite revenue falling 13.4% to $43.56 M in H1 2025globenewswire.com. Gross profit was thin at $0.55 M (1.3% margin), down from $1.14 M (2.3% margin) a year agoglobenewswire.com, reflecting razor-thin margins in the bunkering
4 November 2025
·

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop